Fangxuan Li

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 7

Top Topics

Cancer Stem Cells

Long Non Coding Rna

Top Venues

Cancer management and research

Oxidative medicine and cellular longevity

International journal of nanomedicine

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Menghui Li, Lijuan Wei, Fangxuan Li, Yanyan Kan, Xiaofeng Liang, Huan Zhang, Juntian Liu
High Risk Thyroid Nodule Discrimination and Management by Modified TI-RADS. Cancer management and research 13 (2021)
Ying Chen, Lei Zhang, Fangxuan Li, Jindong Sheng, Changxiao Xu, Dan Li, Hu Yu, Wenxin Liu
Combination of Chemotherapy and Photodynamic Therapy with Oxygen Self-Supply in the Form of Mutual Assistance for Cancer Therapy. International journal of nanomedicine 16 (2021)
Yanyan Kan, Juntian Liu, Fangxuan Li
High Expression of Nuclear Transcription Factor-κB is Associated with Cisplatin Resistance and Prognosis for Ovarian Cancer. Cancer management and research 12 (2020)
Yanfang Yang, Jing Zhao, Yiran Mao, Gu Lin, Fangxuan Li, Zhansheng Jiang
UBR5 over-expression contributes to poor prognosis and tamoxifen resistance of ERa+ breast cancer by stabilizing β-catenin. Breast cancer research and treatment 184 (3) (2020)
Yang Zhao, Lijuan Wei, Juntian Liu, Fangxuan Li
Chemoresistance was correlated with elevated expression and activity of indoleamine 2,3-dioxygenase in breast cancer. Cancer chemotherapy and pharmacology 85 (1) (2019)
Fangxuan Li, Yao Sun, Jinchao Huang, Wengui Xu, Juntian Liu, Zhi-Yong Yuan
CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis. Cancer medicine 8 (17) (2019)
Xiaobei Zhang, Fangxuan Li, Ying Zheng, Xiaokun Wang, Kaiyuan Wang, Yue Yu, Hongwei Zhao
Propofol Reduced Mammosphere Formation of Breast Cancer Stem Cells via PD-L1/Nanog In Vitro. Oxidative medicine and cellular longevity 2019 (2019)